Benjamin N. Rome
Benjamin N. Rome publishes mostly in Economics and Econometrics, Family Practice and Pharmacology, on topics such as Pharmaceutical Economics and Policy, Health Systems, Economic Evaluations, Quality of Life and Medication Adherence and Compliance.
- World rank
- #178,682 of 7,710,434 ranked researchers
- Rank in United States
- #66,729 of 1,627,098
- Works
- 164
- Citations
- 4.2k
- Citations per work
- 25.8
What does Benjamin N. Rome research?
Benjamin N. Rome's work is mostly in Economics, Econometrics and Finance (46%), Medicine (13%), Pharmacology, Toxicology and Pharmaceutics (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Social Sciences7545.6%
- Everything else5030.2%
- Health Sciences2213.3%
- Medicine2213.3%
- Life Sciences1810.9%
- 1Economics and Econometrics46% of their works
- 2Family Practice7% of their works
- 3Pharmacology6% of their works
- 4Immunology5% of their works
- 5Pediatrics, Perinatology and Child Health3% of their works
- 6Surgery3% of their works
Research topics
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Medication Adherence and Compliance
- Pharmaceutical industry and healthcare
- Healthcare Policy and Management
- Economic and Financial Impacts of Cancer
- Biosimilars and Bioanalytical Methods
- Pharmaceutical studies and practices
Which keywords describe Benjamin N. Rome's research?
The keywords of their largest research topics: Pharmaceutical Industry, Drug Development Costs, Generic Drugs, Cost-effectiveness Analysis, Quality of Life, Medication Adherence, Clinical Trials and Patient Compliance.
- Off-Label Drug Use
- Biosimilars
- Cost of Care
- Health Care Spending
- Conflict of Interest
- Patient Compliance
- Medication Adherence
- Cost-effectiveness Analysis
- Drug Development Costs
- Pharmaceutical Industry
- Generic Drugs
- Quality of Life
- Clinical Trials
- Treatment Adherence
- Research Outcome
- Insurance Markets
- Financial Toxicity
- Immunogenicity
- Pediatric Pharmacokinetics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Pharmaceutical Industry1232 topics
- Drug Development Costs951 topic
- Generic Drugs951 topic
- Cost-effectiveness Analysis721 topic
- Quality of Life721 topic
- Medication Adherence492 topics
- Clinical Trials432 topics
- Patient Compliance341 topic
- Treatment Adherence341 topic
- Conflict of Interest281 topic
- Research Outcome281 topic
- Health Care Spending241 topic
- Insurance Markets241 topic
- Cost of Care201 topic
- Financial Toxicity201 topic
- Biosimilars181 topic
- Immunogenicity181 topic
- Off-Label Drug Use151 topic
- Pediatric Pharmacokinetics151 topic
Where does Benjamin N. Rome work?
Benjamin N. Rome's main affiliation in the publication record is Brigham and Women's Hospital, United States.
How many publications and citations does Benjamin N. Rome have?
OpenAlex counts 164 works and 4,224 citations for Benjamin N. Rome, an h-index of 25, ranking #178,682 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Benjamin N. Rome. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.